Skip to content

Multi Point Pacing and Continuous Atrioventricular Conduction OPtimization of Cardiac Resynchronization Therapy: PPAP-CRT

Multi Point Pacing and Continuous Atrioventricular Conduction OPtimization of Cardiac Resynchronization Therapy - PPAP-CRT

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052210081
Enrollment
50
Registered
2021-09-09
Start date
2022-03-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure(HF) patients who are indicated for CRT-D device Heart Failure

Interventions

Both MultiPole Pacing feature and CRT AutoAdapt feature ON

Sponsors

Kusano Kengo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A patient who has never received CRT 2. A patient who is eligible for CRT according to the guideline of The Japanese Circulation Society(JCS) and scheduled for implantation of CRT-D 3. A patient with a fixed residence who can follow the scheduled follow-up 4. A patient who has signed and dated the informed consent

Exclusion criteria

Exclusion criteria: 1. A patient who is suffering from AV block (excluding atrial conduction time 250 ms or more) 2. A patient who is suffering from chronic atrial fibrillation 3. A patient who underwent tricuspid valve surgery or has tricuspid cardiac surgery planned 4. A patients who has a life expectancy of less than 2 years with a non-cardiac cause 5. A patient who is pregnant, breastfeeding or may become pregnant 6. A patient who is less than 20 years of age at the time of consent 7. A patient who is already included or will enroll in another interventional study during this study 8. A patient who is judged by the Principal Investigator (PI) or the Sub-Investigator (SI) as ineligible for participation in this study due to another reason

Design outcomes

Primary

MeasureTime frame
CRT responder rate at 6 months after CRT-D implantation

Secondary

MeasureTime frame
1. Responder rate in 24 months 2. Change in cardiac function (LVEF, LVESV, LVEDV) by myocardial perfusion scintigraphy 3. Change in echocardiogram (LVEF, LVESV, LVEDV) 4. Survival rate and non-incidence rate of cardiovascular event 5. Change in NYHA Class 6. Change in QRS width on EKG 7. Change in serum brain natriuretic peptide(BNP) 8. Clinical composite score 9. Change in QOL questionnaire 10. New onset of atrial fibrillation

Contacts

Public ContactYuko Inoue

National Cerebral and Cardiovascular Center

yuko@ncvc.go.jp+81-6-6170-1070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026